New off-the-shelf immunotherapy for metastatic kidney cancer could help improve outcomes
UCLA researchers have developed a new kind of immunotherapy that uses specially engineered immune cells equipped with built-in weapons to attack kidney cancer tumors and reprogram their protective environment –…